Cost Curve

Why Hospitals Escape Responsibility for Rising Health Costs, and Nine Other Stories for a Summer Friday

Brian Reid

The Implications of Merck’s Move to Price Its Cholesterol Pill at $315 a Month

And UnitedHealth Group’s revenues topped $100 billion -- again -- last quarter

Brian Reid

CVS Caremark Settles Its FTC Insulin Lawsuit, Pledging Changes to the PBM Business Model

Brian Reid

The 340B Program Topped $100 Billion in Annual Sales Last Year; Big Hospitals Continue to Dominate

Plus TrumpRx’s June site visits sunk to their lowest level since the site launched in February

Brian Reid

A Spate of Articles on GLP-1 Value and Reimbursement Drive Home a Frustrating Reality

“This is the first time that we’ve seen significant restrictions on access to drugs that are safe and effective.”

Brian Reid

Nearly a Third of Prescriptions Are Rejected by Insurers, and the Problem Is Getting Worse, JAMA Analysis Finds

Brian Reid

Today’s Top 10: The Latest on Efforts to Break Up Insurance Companies, a Passel of 340B Links, and Solutions to Cell and Gene Therapy Coverage Dilemmas

Brian Reid

A Florida Hospital With $400 Million in 340B Pharmacy Revenue Is Suing to Stop a New Lilly Policy

And that lawsuit includes a surprising level of detail on 340B prices

Brian Reid

More 340B Legislation Released, Sharpening Where -- and How -- Reform Might Happen

And Lilly bakes the CMS Bridge demo into its ad campaigns

Brian Reid